Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.250
-0.050 (-3.85%)
At close: Jun 27, 2025, 4:00 PM
1.400
+0.150 (12.00%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $76.73 million as of June 27, 2025. Its market cap has decreased by -88.73% in one year.
Market Cap
76.73M
Enterprise Value
-168.74M
1-Year Change
-88.73%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $76.73M, a decrease of -89.60%. That is a compound annual growth rate of -36.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 76.73M | -90.43% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | 806.10M | 9.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.09B |
| Johnson & Johnson | 365.12B |
| AbbVie | 329.38B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.70B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.42B |
| AstraZeneca | 216.45B |